COMMUNIQUÉS West-GlobeNewswire

Calithera Biosciences Presents New Preclinical Data for CB-708 at AACR Annual Meeting 2019
02/04/2019
Oral CD73 inhibitor enhances the effect of checkpoint blockade and chemotherapy SOUTH SAN FRANCISCO, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical stage biotechnology [...]
Myriad Women’s Health to Highlight New Studies Demonstrating the Superior Clinical Performance of the Foresight® and Prequel™ Prenatal Tests
02/04/2019
SALT LAKE CITY, April 02, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in personalized medicine, today announced that its Myriad Women’s Health business unit will present results from [...]
Matinas BioPharma Reports 2018 Financial Results and Provides Corporate Update
02/04/2019
– Key focus on advancing the development of MAT9001, a potential best-in-class cardiovascular therapy in what is projected to be a new, multi-billion dollar prescription-only omega-3 market – – Company continues to [...]
Helius Medical Technologies to Release First Quarter of Fiscal Year 2019 Financial Results on May 9, 2019
02/04/2019
NEWTOWN, Pa., April 02, 2019 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that first [...]
Summit Therapeutics to Present at H. C. Wainwright & Co. Global Life Sciences Conference
02/04/2019
Summit Therapeutics plc (‘Summit’ or the ‘Company’) Summit Therapeutics to Present at H. C. Wainwright & Co. Global Life Sciences Conference Oxford, UK, and Cambridge, MA, US, 2 April 2019 – Summit Therapeutics plc [...]
Zealand Pharma to attend Needham Healthcare Conference
02/04/2019
Press release – No. 06 / 2019 Zealand Pharma to attend Needham Healthcare Conference Copenhagen, April 2, 2019 – Adam Steensberg, Interim Chief Executive Officer, and Marino Garcia, Senior Vice President of Corporate [...]
G1 Therapeutics to Present at the 18th Annual Needham Healthcare Conference
02/04/2019
RESEARCH TRIANGLE PARK, N.C., April 02, 2019 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today announced Chief Executive Officer Mark Velleca, M.D., Ph.D., will present a [...]
Aptose to Present at the H.C. Wainwright Annual Global Life Sciences Conference
02/04/2019
SAN DIEGO and TORONTO, April 02, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage company developing highly differentiated therapeutics that target the underlying mechanisms of [...]
IRADIMED CORPORATION Announces FDA 510(k) Clearance for Neonatal Pulse Oximetry and Capnography Monitoring Using its MRI-Compatible Patient Vital Signs Monitor
02/04/2019
WINTER SPRINGS, Fla., April 02, 2019 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), today announced that it received FDA 510(k) clearance for neonatal use of the pulse oximetry (“SpO2”) and Capnography (“CO2 [...]
Idera Pharmaceuticals Presents ILLUMINATE-101 Data Demonstrating Tilsotolimod Activates Innate and Adaptive Immunity as Monotherapy in Patients with Refractory Solid Tumors at the American Association for Cancer Research (AACR) 2019 Annual Meeting
02/04/2019
– Tilsotolimod activated IFN-α and MHC class II genes in the tumor microenvironment across multiple tumor types – EXTON, Pa., April 02, 2019 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (“Idera”) (NASDAQ: IDRA), a [...]
EyePoint Pharmaceuticals to Present at Upcoming Investor Conferences
02/04/2019
WATERTOWN, Mass., April 02, 2019 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, today [...]
Molecular Templates’ Presentations at the American Association of Cancer Research (AACR) Annual Meeting 2019 Highlight Evolution of ETB Platform
02/04/2019
Presentations from multiple pipeline programs feature data demonstrating continued evidence of forced internalization with CD38 and PD-L1 leads, dramatically improved tolerability in NHP models, enhanced potency, and [...]
Trillium Therapeutics Expands Immuno-Oncology Pipeline With STING Agonist Program
02/04/2019
- Preclinical data presented at the 2019 AACR Annual Meeting TORONTO, April 02, 2019 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (Nasdaq/TSX: TRIL), a clinical-stage immuno-oncology company developing innovative [...]
Arvinas Strengthens Management Team with Internal Appointments of Andy Crew, Ph.D. as Chief Technology Officer and Ian Taylor, Ph.D. as Chief Scientific Officer
02/04/2019
NEW HAVEN, Conn., April 02, 2019 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a biopharmaceutical company creating a new class of therapies that degrades disease-causing proteins, announced that two members of the [...]
Lexicon Pharmaceuticals to Present at Upcoming Investor Conference
02/04/2019
THE WOODLANDS, Texas, April 02, 2019 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Lonnel Coats, President and Chief Executive Officer, will present at the following conference: [...]
ContraFect Announces CEO Transition
02/04/2019
Dr. Roger J. Pomerantz appointed Chairman and CEO Dr. Steven C. Gilman retires and remains on board as Vice Chairman YONKERS, New York, April 02, 2019 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX) , a [...]
Nabriva Therapeutics to Present at the Needham and Company 18th Annual Healthcare Conference
02/04/2019
DUBLIN, Ireland and KING OF PRUSSIA, Pa., April 02, 2019 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the development of innovative anti-infective agents to treat [...]
Athenex Announces Appointment of John Koh as a New Board Member
02/04/2019
BUFFALO, N.Y., April 02, 2019 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]
Unum Therapeutics to Present at Two Upcoming Investor Conferences
02/04/2019
CAMBRIDGE, Mass., April 02, 2019 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. (NASDAQ: UMRX), a clinical-stage biopharmaceutical company focused on the development of cellular immunotherapies to treat cancer based on its [...]

Pages